Reference
Zhang L, et al. Bevacizumab Combined with Icotinib Overcomes Osimertinib Resistance in a Patient of Non-Small Cell Lung Cancer. Chinese Medical Sciences Journal 34: 292-296, No. 4, Dec 2019. Available from: URL: http://doi.org/10.24920/003487
Rights and permissions
About this article
Cite this article
Bevacizumab/icotinib/osimertinib. Reactions Weekly 1791, 49 (2020). https://doi.org/10.1007/s40278-020-74894-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-74894-1